ISSN: 2222-6990
Open access
Hemp is considered a cannabis species with significant health benefits. There is growing evidence that hemp (Cannabis Sativa L.) can be used as a therapy for neurological disorders, autism, depression, Parkinson's disease, and cancer. The Dangerous Drugs Act 1952, however, prohibits cannabis cultivation, production, distribution, import, export, possession, and abuse in Malaysia. The purpose of this study is to examine the Islamic legal perspective surrounding cannabis cultivation, which has been extensively discussed in recent years, particularly in terms of benefits to health and medical conditions. It will then examine the basics of the need for planting the tree in the context of the Maqasid Shari’ah perspective with special concentration on the principle of maslahah (benefits) and mafsadah(harmful). Based on qualitative research, content analysis is adopted to obtain the views of fuqaha regarding the law of cultivation of hasyish (marijuana), khasykhasy (poppy), tabgh (tobacco), as well as relevant current fatwas from several legal institutions. This study recommends that it is extremely pertinent to consider the provisions of National Law when determining the law at present along with the reflection derived from the maslahah and mafsadah devine principles. These findings indicate that hemp species are pure and clean, and are not considered impurities. To make cultivation permissible, however, specific and comprehensive guidelines are needed to ensure the consumption and use of hemp is not abusive and to prevent the consumption of harmful effects for society at large. Researchers believe this is the first academic study on the hem position since it has never been discussed before. Further research could be conducted in the future regarding the specific requirements to be included in the proposed guideline for hemp cultivation and consumption. Taking into account Islamic rulings while simultaneously taking into consideration of technical and legal aspects is crucial to achieving a holistic approach to dealing with the legality of hemp.
Agrawal, A., Madden, P. A., Bucholz, K. K., Heath, A. C., and Lynskey, M. T. (2014). Initial reactions to tobacco and cannabis smoking: A twin study. Addiction, Vol 109(4), pp: 663–671.
Al-Dustur. (2018). Hukm Zira'at al-Mukhaddarat wa al-Ittijar biha. Accessed from https://www.dostor.org/2345891 on 3 May 2022.
Al-Qaradawi, Y. (2020). Ma Hukm Zira'at al-Hasyisy wa al-Tabg. Accessed from https://www.youtube.com/watch?v=pKG7YeyzJ5E on 3 May 2022.
Al-Tabrani, S. ibn A. (1994). Al-Mucjam al-Awsat. Tahqiq oleh Tariq ibn cIwad Allah dan Abd al-Muhsin ibn Ibrahim al-Husayni. Kaherah : Dar al-Haramayn.
Baker, D., Pryce, G., Giovannoni, G., and Thompson, A. J. (2003). The therapeutic potential of cannabis. The Lancet Neurology, Vol 2, pp: 291–298.
Aijaz, B. (2021). From Canada to Uruguay, Here Are Some Of The Countries Where Marijuana Is Legal. Accessed from https://www.indiatimes.com/trending/social-relevance/countries-where-marijuana-is-legal-551710.html on 3 June 2022.
BH Online. (2021). UniMAP kaji tanaman 'hemp'. Accessed from https://www.bharian.com.my/berita/pendidikan/2021/09/862187/unimap-kaji-tanaman-hemp on 2 May 2022.
BH Online. (2019). Kerajaan dalam proses benar penanaman 'hemp' untuk tujuan penyelidikan. Accessed from https://www.bharian.com.my/berita/nasional/2019/11/625523/kerajaan-dalam-proses-benar-penanaman-hemp-untuk-tujuan-penyelidikan on 2 May 2022.
Busse, F., L. Omidi, Timper, K., Leichtle, A., Windgassen, M., Kluge, E., and Stumvoll, M. (2008). Lead poisoning due to adulterated marijuana. New England Journal of Medicine, Vol 358(15), pp: 1641–1642.
De Lago, E., and Fernandez-Ruiz, J. (2007). Cannabinoids and neuroprotection in motor-related disorders. CNS and Neurological Disorders in Drug Targets, Vol 6(6), pp: 377–387.
Isnaini, E. (2017). Penggunaan Ganja Dalam Ilmu Pengobatan Menurut Undang-Undang Nomor 35 Tahun 2009 Tentang Narkotika. Jurnal Independent. Vol 5, No 2, pp: 46-54.
Grotenhermen, F. (2003). Pharmacokinetics and pharmacodynamics of cannabinoids. Clinical Pharmacokinetics, Vol 42(4), pp: 327–360.
Grotenhermen, F., & Muller-Vahl, K. (2012). The Therapeutic Potential of Cannabis and Cannabinoids. Deutsches Arzteblatt International, Vol 109(29–30), pp: 495–501.
Hofmann, M. E., and Frazier, C. J. (2013). Marijuana, endocannabinoids, and epilepsy: Potential and challenges for improved therapeutic intervention. Experimental Neurology, Vol 244, pp: 43–50.
Salman, N. A. (2012) Hukm al-Islam fi al-Mukhaddarat. 17 Mei 2012. Accessed from https://www.aliftaa.jo/Article.aspx?ArticleId=161#.Ymi67tpBw2w on 2 May 2022.
Ibn Majah, Muhammad ibn Yazid al-Qazwayni. (2009). Sunan Ibn Majah. Syucayb al-Arna’ut et.al (tahqiq). T.tp : Dar al-Risalah al-cAlamiyyah.
Izzo, A. A., Borrelli, F., Capasso, R., Di Marzo, V., & Mechoulam, R. (2009). Nonpsychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb. Trends in Pharmacological Sciences, Vol 30(10), pp: 515–527.
Jerome, H. C. (2016), Industrial Hemp in North America: Production, Politics and Potential, Agronomy, Vol 6(4), 58; https://doi.org/10.3390/agronomy6040058).
Johnson. (2009), Defining Hemp: A Fact Sheet, in https://www.everycrsreport.com/files/20190322_R44742_1b0195c6aa7e2cad29256c85a8574347c1ee833d.pdf).
Jones, N. A., Hil, lA. J., Smith, I., Bevan, S. A., Williams, C. M., Whalley, B. J., and Stephens, G. J. (2010). Cannabidiol displays antiepileptiform and antiseizure properties in vitro and in vivo. Journal of Pharmacology and Experimental Therapeutics, Vol 332(2), pp: 569–577.
Leweke, F. M., Mueller, J. K., Lange, B., and Rohleder, C. (2016). Therapeutic potential of cannabinoids in psychosis. Biological Psychiatry, Vol 79(7), pp: 604–612.
Malaysiakini. (2021). Ganja rawat tikus Alzheimer: Respon positif - penyelidik UPM. Accessed from https://www.malaysiakini.com/news/593431 on 2 May 2022
McLaren, J., Swift, W., Dillon, P., and Allsop, S. (2008). Cannabis potency and contamination: A review of the literature. Addiction, Vol 103(7), pp: 1100–1109.
McPartland, J. M., Blanchon, D. J., and Musty, R. E. (2008). Cannabimimetic effects modulated by cholinergic compounds. Addiction Biology, Vol 13(3–4), pp: 411–415.
Mikuriya, T. H. (1969). Marijuana in medicine: past, present and future. California medicine, Vol 110(1), pp: 34–40.
Muslim, Abu al-Husayn (t.t), Sahih Muslim. Muhammad Fu’ad cAbd al-Baqi (Tahqiq). Beirut : Dar Ihya al-Turath al-cArabi.
Jamal, M. (2020). Ma Hukm Zira'at al-Mawad al-Mukhaddarah wa al-Mal al-Natij 'an al-Ittijar fiha? Dar al-Ifta' Tujib, 16 December 2020. Accessed from https://www.vetogate.com/4240280 on 2 May 2022. Religion and World. Retrieved at https://www.vetogate.com/4240280.
Potter, D. J., Clark, P., & Brown, M. B. (2008). Potency of D9 –THC and Other Cannabinoidsin Cannabis in England in 2005: Implications for Psychoactivity and Pharmacology. Journal of Forensic Science, Vol 53(1), pp: 1–5
Raber, J. C., Elzinga, S., and Kaplan, C. (2015). Understanding dabs: Contamination concerns of cannabis concentrates and cannabinoid transfer during the act of dabbing. Journal of Toxicological Science, Vol 40(6), pp: 797–803.
Rock, E. M., Goodwin, J. M., Limebeer, C. L., Breuer, A., Pertwee, R. G., Mechoulam, R., & Parker, L. A. (2011). Interaction between non-psychotropic cannabinoids in marihuana: effect of cannabigerol (CBG) on the anti-nausea or anti-emetic effects of cannabidiol (CBD) in rats and shrews. Psychopharmacology, Vol 215, pp: 505–512.
Thomas, A., Baillie, G. L., Phillips, A. M., Razdan, R. K., Ross, R. A., and Pertwee, R. G. (2007). Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro. British Journal of Pharmacology, Vol 150(5), pp: 613–623.
Thomas, B. F., and Pollard, G. T. (2016). Preparation and distribution of cannabis and cannabis-derived dosage formulations for investigational and therapeutic use in the United States. Frontiers in Pharmacology, Vol 7, pp: 285.
Underhill, A. P. (1997). Current issues in Chinese Neolithic archeology. Journal of World Prehistory, Vol 11(2), pp: 103–160, dalam Pisanti S, Bifulco M. MedicalCannabis: A plurimillennial history of an evergreen. Journal of Cell Physiology. (2019), Vol 234, pp: 8342–8351.https://doi.org/10.1002/jcp.27725PISANTIANDBIFULCO|8351).
Ware, M. A., Adams, H., & Guy, G. W. (2005). The medicinal use of cannabis in the UK: results of a nationwide survey. International Journal of Clinical Practice, Vol 59(3), pp: 291–295.
Wee, M., Hassan, A., & Abdullah, A. (2022). Legalization of Hemp and the Contribution to Japanese Economy. WILAYAH : The International Journal of East Asian Studies, Vol 11(1), pp: 69–82. Retrieved from
http://jice.um.edu.my/index.php/IJEAS/article/view/34575
In-Text Citation: (Mahaiyadin et al., 2022)
To Cite this Article: Mahaiyadin, M. H., Harun, N., Suhaimi, R., & Samori, Z. (2022). Islamic Legal Perspective on Hemp Cultivation in Malaysia: Wonder or Evil? International Journal of Academic Research in Business and Social Sciences, 12(12), 173–187.
Copyright: © 2022 The Author(s)
Published by Human Resource Management Academic Research Society (www.hrmars.com)
This article is published under the Creative Commons Attribution (CC BY 4.0) license. Anyone may reproduce, distribute, translate and create derivative works of this article (for both commercial and non0-commercial purposes), subject to full attribution to the original publication and authors. The full terms of this license may be seen at: http://creativecommons.org/licences/by/4.0/legalcode